MAN2A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.093000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.388400E-01
Normal-vs-Stage2
4.650800E-01
Normal-vs-Stage3
6.187900E-02
Normal-vs-Stage4
6.359800E-01
Stage1-vs-Stage2
6.277800E-01
Stage1-vs-Stage3
8.428300E-02
Stage1-vs-Stage4
3.505400E-01
Stage2-vs-Stage3
5.102000E-03
Stage2-vs-Stage4
1.201000E-01
Stage3-vs-Stage4
2.119900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.573400E-01
Normal-vs-AfricanAmerican
6.957800E-01
Normal-vs-Asian
1.742440E-01
Caucasian-vs-AfricanAmerican
2.256600E-01
Caucasian-vs-Asian
3.530600E-01
AfricanAmerican-vs-Asian
5.755600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.267400E-01
Normal-vs-Female
4.099200E-01
Male-vs-Female
8.534200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.714200E-01
Normal-vs-Age(41-60Yrs)
7.073000E-01
Normal-vs-Age(61-80Yrs)
3.251800E-01
Normal-vs-Age(81-100Yrs)
1.503790E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.836600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.542400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.470400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.902500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.671900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.699200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.558040E-01
Normal-vs-Daily Drinker
6.704100E-02
Normal-vs-Weekly Drinker
4.281800E-01
Normal-vs-Occasional Drinker
5.347000E-01
Normal-vs-Social Drinker
6.886000E-01
Non Drinker-vs-Daily Drinker
2.625000E-01
Non Drinker-vs-Weekly Drinker
6.563600E-01
Non Drinker-vs-Occasional Drinker
3.329600E-01
Non Drinker-vs-Social Drinker
3.628800E-01
Daily Drinker-vs-Weekly Drinker
2.362400E-01
Daily Drinker-vs-Occasional Drinker
9.108200E-02
Daily Drinker-vs-Social Drinker
1.369180E-01
Weekly Drinker-vs-Occasional Drinker
7.298200E-01
Weekly Drinker-vs-Social Drinker
6.314600E-01
Occasional Drinker-vs-Social Drinker
8.389800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.394800E-01
Normal-vs-Grade 2
1.334380E-01
Normal-vs-Grade 3
1.055820E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.908780E-01
Grade 1-vs-Grade 3
8.357700E-02
Grade 1-vs-Grade 4
3.394800E-01
Grade 2-vs-Grade 3
3.906200E-01
Grade 2-vs-Grade 4
1.334380E-01
Grade 3-vs-Grade 4
1.055820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.334000E-01
Normal-vs-NonDiabetic
2.233600E-01
Diabetic-vs-NonDiabetic
3.421600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.733500E-02
Normal-vs-NoPancreatitis
3.392800E-01
Pancreatitis-vs-NoPancreatitis
2.943600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.734800E-01
Normal-vs-N1
4.534800E-01
N0-vs-N1
3.786200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.369800E-01
Normal-vs-TP53-NonMutant
7.438400E-01
TP53-Mutant-vs-TP53-NonMutant
7.169400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
